Total trials
517
Active
1
Phase 3
130
Total enrollment
319,701
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Ocular Hypertension74
- Glaucoma32
- Glaucoma, Open-Angle31
- Dry Eye Syndromes29
- Macular Edema21
- Muscle Spasticity17
- Overactive Bladder17
- Retinal Vein Occlusion15
Frequently asked questions about Allergan
- How many clinical trials does Allergan have on ClinicalTrials.gov?
- Allergan is listed as the lead sponsor on 517 clinical trials in ClinicalTrials.gov, 1 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Allergan's trials are in Phase 3?
- 130 of Allergan's trials are in Phase 3.
- What therapeutic areas does Allergan focus on?
- Allergan's most-studied conditions on ClinicalTrials.gov are Ocular Hypertension, Glaucoma, Glaucoma, Open-Angle, Dry Eye Syndromes, Macular Edema.